Terbutaline
Articles · Medicine Compliance Aid Stability · Lactation Safety Information · Published , updated
45311002
Articles
28th November 2018
Shortage of Bricanyl® Turbohaler® (terbutaline)
Astra Zeneca UK Ltd, the manufacturer of Bricanyl® Turbohaler® have informed healthcare professionals that they are currently experiencing an interruption to normal supplies. This is… News Respiratory disorders Shortages and discontinuations Terbutaline
20th April 2017
Safety in Lactation: Drugs for obstructive airways disease
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Bronchodilators Most bronchodilators are considered to… Aclidinium bromide Aminophylline Bambuterol Beclometasone Budesonide Ciclesonide Ephedrine Fluticasone Formoterol Glycopyrronium Indacaterol Ipratropium Mepolizumab Mometasone Montelukast Nedocromil Obstetrics and gynaecology Olodaterol Omalizumab Paediatric and neonatal medicine Respiratory disorders Roflumilast Safety in Lactation Salbutamol Salmeterol Sodium cromoglicate Terbutaline Theophylline Tiotropium Umeclidinium bromide Umeclidinium bromide + Vilanterol Zafirlukast
25th February 2014
Which commonly used nebuliser solutions are compatible?
Mixing of nebuliser solutions should only be undertaken in the best interests of the patient and only by a person competent and willing to do… Budesonide Colistimethate Fluticasone Ipratropium Pharmaceutical Stability Q&A Respiratory disorders Salbutamol Salbutamol + Ipratropium Terbutaline TobramycinMedicine Compliance Aid Stability
Bricanyl · AstraZeneca UK Ltd
AstraZeneca UK Ltd
Bricanyl
Tablet 5mg
G1 · Green 1 · Stability data indicates that the drug is suitable for CAs and there are no theoretical concerns with the product.
Airtight container
Protect from light
Protect from light and store in tight, light-resistant containers.
29th September 2015
Lactation Safety Information
Inhalation
Inhalation
-
Selective beta2 agonist bronchodilator
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties
21st April 2017
Oral
Oral
Salbutamol/ Terbutaline inhaler
Selective beta2 agonist bronchodilator
Very limited published evidence of safety
Small amounts in breast milk
Higher milk levels than after inhalation administration expected
Used in infants >1 month
21st April 2017
Parenteral
Parenteral
Terbutaline inhaler/oral
Selective beta2 agonist bronchodilator
No published evidence of safety
Higher milk levels than after inhalation or oral administration expected
Used in infants >1 month
21st April 2017